Valiant Laboratories Limited — Board Meeting, 07-02-2025: Outcome of Board Meeting

The Board of Directors has approved the audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. Key highlights include total income for the quarter at ₹36.81 crore, with a net profit of ₹16.01 crore. The consolidated results also reflect a total income of ₹36.81 crore and a profit attributable to owners of ₹23.45 crore. The meeting included updates on the risk management committee and designations for determining materiality for disclosures.